Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02328807 · ClinicalTrials.gov registry record · NA

Focal Prostate Radio-Frequency Ablation

A NA study of Prostate Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT02328807 is a NA study of Prostate Cancer that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 6 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02328807, a NA study of Prostate Cancer, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to evaluate the safety and efficacy of focal (targeted) Radio-Frequency Ablation (RFA) in men with low or intermediate-risk, clinically localized prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE Radio-Frequency Ablation (RFA)

Study Locations (1)

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2014-12-29
Est. Completion 2021-07-08
Phase NA

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02328807

The ClinicalTrials.gov registry entry for NCT02328807 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (99% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radio-Frequency Ablation (RFA) is the first listed.

NCT02328807 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02328807 about?

NCT02328807 is a clinical study titled "Focal Prostate Radio-Frequency Ablation". The main purpose of this study is to evaluate the safety and efficacy of focal (targeted) Radio-Frequency Ablation (RFA) in men with low or intermediate-risk, clinically localized prostate cancer.

What is the current status of trial NCT02328807?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2014-12-29. Estimated completion is 2021-07-08.

What conditions does trial NCT02328807 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02328807?

The interventions under investigation include: Radio-Frequency Ablation (RFA) (PROCEDURE).

Who is sponsoring clinical trial NCT02328807?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02328807 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.